16
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Proinflammatory Cytokines Are Not Released in the Circulation Following Acute Pulmonary Thromboembolism in Pigs

, , , &
Pages 29-35 | Published online: 09 Jul 2009

  • Strieter RM, Kunkel SL. Acute lung injury: The role of cytokines in the elicitation of neutrophils. J Invest Med. 1994;42:640-651.
  • Cannon JG, Thompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, lonnemann G, Corsetti J, Chernow B. Circulating interleukin 1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990; 161:79-84.
  • Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome. Ann Intern Med. 1993;119:771778.
  • Tomashefski JFJr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesion of the adult respiratory distress syndrome. Am J Pathol. 1983; 112:112126.
  • Fein AM, Catalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin. 2000;16:289-317.
  • Huet Y, Lemaire F, Brun-Buisson C, Knaus WA, Teisseire B, Payen D, Mathieu D. Hypoxemia in acute pulmonary embolism. Chest. 1985;88:829-836.
  • Reed GL, Houng AK. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism. Circulation. 1999;99:299-304.
  • Kapsch DN, Metzler M, Silver D. Contributions of prostaglandin F2alpha and thromboxane A2 to the acute cardiopulmonary changes of pulmonary embolism. J Surg Res. 1981;30:522-529.
  • SmuldersYM. Pathophysiology and treatments of haemodynamic instability in acute pulmonary embolism: The pivotal role of pulmonary vasoconstriction. Cardiovasc Res. 2000;48:23-33.
  • Wilson JE 3rd, Pierce AK, Johnson RLJr, Winga ER, Harrell WR, Curry GC, Mullins CB. Hypoxemia in pulmonary embolism, a clinical study. J Gin Invest. 1971;5:481491.
  • Malik AB, van der Zee H. Time course of pulmonary vascular response to micro-embolization. J Appl Physiol. 1977;43:51-58.
  • Huval WV, Mathieson MA, Stemp Ll, Dunham BM, Jones AG, Shepro D, Hechtman HB. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism. Ann Surg. 1983;197:220-225.
  • Nakos G, Kitsiouli El, Lekka ME. Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med. 1998:158:1504-1510.
  • Todd MH, Cragg DB, Forrest JB, AIi M, McDonald JW. The involvement of prostaglandin s and thromboxane in the response to pulmonary embolism in anesthetized rabbits and isolated perfused lungs. Thromb Res. 1983;30:8190.
  • Sofia M, Faraone S, Alifano M, Micco A, Albisinni R, Maniscalco M, Di Minno G. Endothelin abnormalities in patients with pulmonary embolism. Chest. 1997:111:544-549.
  • Rinaldo JE, Christman JW. Acute respiratory distress syndrome: Pathogenesis. In: Fishman AP, ed. Textbook of Pulmonary Diseases and Disorders (3rd ed). New York: McGraw-Hill; 1997:2537-2548.
  • Tracey KJ, Cerami A. Tumor necrosis factor: An updated review of its biology. Crit Care Med. 1993;21(suppl):S415-S422.
  • Aggarwal BB. Tumor necrosis factors receptor associated signalling molecules and their roles in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis. 2000;59(suppl):i6-i16.
  • Marsh CB, Moore SA, Pope HA, Wewers MD. IL-1ra suppresses endotoxin-induced IL-1 beta and TNF-alpha release from mononuclear phagocytes. Am J Physiol Lung Cell MoI Physiol. 1994;267:L39-L45.
  • Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J lmmunol. 1993; 150:55855595.
  • Luce JM. Acute lung injury and the acute respiratory distress syndrome. Crit Care Med. 1998;26:69-376.
  • Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. CurrOpin Hematol. 2000;7:178-182.
  • Ferro TJ, Malik AB. Mechanisms of lung vascular injury and edema after pulmonary microembolism. J Crit Care. 1989;4:118-126.
  • CasaleTB, Carolan EJ. Combination of IL-8 plus TNF alpha induces additive neutrophil migration. Allergy Asthma Proc. 1999;20:361-363.
  • Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. lnterleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition .J Qin Invest. 1988;1:1162-1172.
  • Glauser MP, Neumann D, Baumgartner JD, Cohen J. Pathogenesis strategies for prevention and treatment of septic shock. Clin Infect Dis. 1994;18(suppl):S205-S216.
  • Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolf SM. Detection of circulating tumor necrosis after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
  • Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J lmmunol. 1991;21:2177-2184.
  • Mozes T, Zijlstra FJ, Heiligers JP, Tak CJ, Ben-Efraim S, Sazena PR, Bonta IL, Saxena PR. Sequential release of TNF, PAF and eicosanoids during endotoxin shock in anesthetized pigs; Protective effects of indomethacin. Br J Pharmacol. 1991;104:691-699.
  • Bernard GR, Reines HD, Halushka PV, Higgins SB, Metz CA, Swindell BB, Wright PE, Watts FL, Vrbanac JJ. Prostacycline and thromboxane A2 formation is increased in human sepsis syndrome. Am Rev Respir Dis. 1991;144:1095-1101.
  • Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 1996;64:1095-1101.
  • Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, Smith C, Kenney JA, Wesdorp MB, Meijer S, Cuesta MA, Abouhanze A, Copeland EM 3rd, Giri J, Sims JE, Moldawer LL, Oldenburg HS. Increased soluble interleukin-1 type Il receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood. 1996:87:3282-3288.
  • Rogy MA, Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. JAm Coll Surg. 1994;78:132-138.
  • Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863-870.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.